Lateral flow has grown beyond the home pregnancy test and has the potential to give people access to a range of quick, affordable and accurate tests they can perform at home to screen for a ...

Researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons learnt from the severe acute respiratory syndrome coronavirus ...

If you test regularly, you'll have peace of mind that you're not unknowingly spreading the virus to loved ones or strangers. How do I order free lateral flow tests to be sent to me?

However, a new study has found lateral flow tests are more accurate than previously reported and cannot be compared directly to how PCR tests work.

Although lateral flow immunoassays have been central to clinical diagnostics for over six decades, their public health use during the pandemic cast a new spotlight on this veteran testing technology.

This article explores the use of colloidal gold for lateral flow testing, and explores the benefits of using gold colloid for point-of-care diagnostics.

The AffiDX® SARS-CoV-2 antigen lateral flow test has been developed using Avacta’s proprietary Affimer® platform to identify individuals with a higher viral load of the SARS-CoV-2 virus who ...

While lateral flow tests are good for giving qualitative data, such as if you have a virus or not, doctors would like to have versions of these easy-to-use diagnostics that give quantitative data.

The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study ...

"The widespread use of antigen lateral flow devices was a significant moment not just during the pandemic, but has also introduced diagnostic testing to many more people in society.

A lateral flow test is another term for an antigen test. While medical experts have been using these terms interchangeably with COVID-19 tests, researchers were using lateral flow technology long ...

"The ability to rapidly identify high-risk patients at the Point-of-Care by quantifying their nucleosome levels using a simple lateral flow device could enable quicker clinical decision making and ...